TSHA R&D Expenses
Taysha Gene Therapies Inc · R&D Expenses
TSHA R&D Expenses
Latest reported$38.64Mperiod ending
TSHA Quarterly R&D Expenses ($987.00K → $38.64M)
Quarterly R&D Expenses
High-resolution chart · PNG
TSHA r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 38,636,000 | |
| 33,809,000 | |
| 24,653,000 | |
| 25,459,000 | |
| 20,141,000 | |
| 15,565,000 | |
| 15,325,000 | |
| 14,946,000 | |
| 15,073,000 | |
| 20,657,000 | |
| 12,682,000 | |
| 11,791,000 | |
| 19,791,000 | |
| 12,514,000 | |
| 13,861,000 | |
| 16,774,000 | |
| 23,506,000 | |
| 38,182,000 | |
| 37,918,000 | |
| 39,528,000 | |
| 30,643,000 | |
| 23,854,000 | |
| 12,260,000 | |
| 11,057,000 | |
| 3,062,000 | |
| 5,514,000 | |
| 987,000 |